Hyun Chul Lee

Hyun Chul Lee
Name	Hyun Chul Lee
Native name	이현철
Birth date	1965
Birth place	Seoul, South Korea
Nationality	South Korean
Alma mater	Seoul National University; Stanford University; University of Cambridge
Occupation	Physician; Researcher; Professor
Known for	Hepatology; Gastroenterology; Clinical research
Awards	Korean Society of Gastroenterology Award; Ho-Am Prize nominee

Hyun Chul Lee is a South Korean physician, hepatologist, and academic known for clinical research in liver disease, viral hepatitis, and hepatocellular carcinoma. He has held professorships and clinical leadership roles at major institutions, contributed to translational research linking virology and oncology, and participated in international collaborations across Asia, Europe, and North America. His work intersects with major public health initiatives, pharmaceutical development programs, and academic societies in hepatology.

Early life and education

Born in Seoul, Lee completed early schooling in the capital before entering Seoul National University for undergraduate and medical training. He pursued postgraduate clinical training with rotations at tertiary hospitals associated with Seoul National University Hospital and undertook research fellowships that connected him to laboratories affiliated with Stanford University and the University of Cambridge. During his formative years he trained under mentors linked to the Korean Association for the Study of the Liver, the Asian Pacific Association for the Study of the Liver, and collaborated with teams involved in multinational trials sponsored by organizations such as the World Health Organization and the Bill & Melinda Gates Foundation.

Academic and professional career

Lee served on faculty at leading Korean medical schools and rose to leadership positions within departments associated with Yonsei University, Korea University, and Seoul National University. His clinical appointments have included directorships at liver units and advisory roles for hospitals modeled after Asan Medical Center and Samsung Medical Center. He has participated in international exchange programs with the National Institutes of Health, the European Association for the Study of the Liver, and research consortia hosted by Harvard Medical School and Imperial College London. Lee has also been an invited speaker at conferences hosted by the American Association for the Study of Liver Diseases, the European Society of Clinical Microbiology and Infectious Diseases, and the International Liver Congress.

Research and contributions

Lee’s research focuses on chronic viral hepatitis caused by hepatitis B virus and hepatitis C virus, pathogenesis of hepatocellular carcinoma, biomarker discovery, and antiviral therapy development. He contributed to clinical trials of nucleos(t)ide analogues and direct-acting antivirals that involved pharmaceutical partners such as Gilead Sciences, Bristol Myers Squibb, and Roche. His laboratory studies connected viral-host interactions with oncogenic pathways studied at institutions like the Broad Institute and the Wellcome Trust Sanger Institute. Lee has led multicenter cohort studies that intersect with registries maintained by the Korean Liver Cancer Association, the Asia-Pacific Hepatology Research Group, and the International Agency for Research on Cancer. His translational work linked imaging modalities developed with collaborators at Mayo Clinic and Johns Hopkins Hospital to circulating biomarkers validated through collaborations with the European Molecular Biology Laboratory and the National Cancer Institute. Lee has served on guideline panels alongside members of the World Gastroenterology Organisation, the American College of Physicians, and national health agencies such as the Korean Ministry of Health and Welfare.

Publications and selected works

Lee has authored and coauthored numerous peer-reviewed articles in journals including The Lancet, New England Journal of Medicine, Gastroenterology, Journal of Hepatology, and Hepatology. Selected works include multicenter randomized trials on antiviral regimens that were cited by the World Health Organization hepatitis strategy documents, cohort analyses of hepatocellular carcinoma risk cited by the American Association for the Study of Liver Diseases practice guidance, and mechanistic studies of viral persistence referenced by researchers at the Cold Spring Harbor Laboratory and the Max Planck Institute. He has contributed chapters to textbooks published by Oxford University Press and Cambridge University Press and presented keynote lectures at meetings organized by the Asian Pacific Association for the Study of the Liver and the International Congress of Hepatology.

Awards and honors

Lee’s honors include national recognition by the Korean Society of Gastroenterology, lifetime achievement citations from regional hepatology societies, and competitive research grants awarded by agencies such as the National Research Foundation of Korea and the Korean Health Industry Development Institute. His work has been shortlisted for regional prizes sponsored by foundations like the Ho-Am Prize and the Asan Award in Medicine. He has received invited memberships and visiting professorships from institutions including Peking University Health Science Center, University of Tokyo, and McGill University.

Personal life and legacy

Lee maintains a professional focus on mentorship and capacity-building across Asia, Europe, and North America, supervising trainees who have continued careers at institutions such as Stanford University School of Medicine, University College London, and The University of Sydney. Outside clinical work he participates in public health advocacy related to viral hepatitis elimination campaigns supported by UNAIDS and the World Health Organization Regional Office for the Western Pacific. His legacy includes established clinical networks, contributions to antiviral drug development, and an ongoing influence on practice guidelines used by hepatology societies worldwide.

Category:South Korean physicians Category:Hepatologists